Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001816445 | SCV002062709 | uncertain significance | not provided | 2021-10-01 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV001816445 | SCV002770652 | uncertain significance | not provided | 2021-10-13 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002506845 | SCV002815776 | uncertain significance | Autosomal recessive spinocerebellar ataxia 13; Spinocerebellar ataxia 44 | 2022-03-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002541521 | SCV003721691 | uncertain significance | Inborn genetic diseases | 2022-03-04 | criteria provided, single submitter | clinical testing | The c.2909C>T (p.P970L) alteration is located in exon 9 (coding exon 8) of the GRM1 gene. This alteration results from a C to T substitution at nucleotide position 2909, causing the proline (P) at amino acid position 970 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |